Stay updated on Darolutamide in Addition to ADT Clinical Trial
Sign up to get notified when there's something new on the Darolutamide in Addition to ADT Clinical Trial page.

Latest updates to the Darolutamide in Addition to ADT Clinical Trial page
- Check3 days agoChange DetectedThe page now displays a general government-funding notice and updates the site software revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check10 days agoChange DetectedAdded a glossary toggle and color-coded change indicators to explain edits in the record history. Revision notes now show 'No FEAR Act Data' and 'Revision: v3.4.0' with the previous 'Revision: v3.3.4' entry removed.SummaryDifference0.5%

- Check17 days agoChange DetectedNew revisions on 2026-01-14 add updated Contacts/Locations and Study Status for the record, reflecting current recruitment information and contact points. The history also includes a 2025-12-21 entry and removes the 2025-12-02 entry.SummaryDifference0.3%

- Check24 days agoChange DetectedThe revision history now shows an added Revision: v3.3.4 and a removed Revision: v3.3.3 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision: v3.3.3 was added to the page history; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the footer.SummaryDifference0.1%

- Check67 days agoChange DetectedThe history now shows a new version entry (58) on 2025-11-21 and an added Study Status section, reflecting an update to the trial's recruitment/status information.SummaryDifference0.2%

Stay in the know with updates to Darolutamide in Addition to ADT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Darolutamide in Addition to ADT Clinical Trial page.